Background/Aim. Currently used radiopharmaceuticals are nonspecific and most of them are accumulated by benign tumors as well as inflammatory lesions, abscess or granulomatous lesions. Some factors such as the choice of radiopharmaceutical applied, histopathologic type of tumor, its size, location or previous tumor treatment could influence tumor imaging sensitivity. The aim of this study was to investigate accumulation of 99m Tc-methoxy-2-isobutylisonitrile ( 99m Tc-MIBI) by counting early/delayed uptake and release of this radiopharmaceutical inside lung tumors and evaluating possible factors which could be involved in its accumulation. Methods. Two-phase 99m Tc-methoxy-2-isobutylisonitrile single photon emission computed tomography scan (early and delayed scan) was performed in 60 patients with lung tumors (the group 1 -30 benign, and the group 2 -30 malignant tumors). We calculated the uptake ratio on early (early ratio -ER), delayed images (delayed ratio -DR) and retention index (RI). Individual influence of etiology, diameter, localization, and histological type on uptake/release values was evaluated with regression analysis. Results. The values of ER and DR were significantly different in both groups (p < 0.01), showing lower values in benign vs malignant lung tumors (ER 1.36 ± 0.094 and DR 1.25 ± 0.089 vs ER = 1.93 ± 0.106 and DR = 1.7 ± 0.095 respectively). Tumor size showed a significant influence on the change of ER and DR values (p < 0.01), with greater uptake in tumors > 3 cm. RI values showed no significance between the two groups (p > 0.05). Conclusion. The uptake ratio of 99m Tc-methoxy-2-isobutylisonitrile could be a useful index in differentiating lung tumors, while RI has no influence on this. Among the evaluated factors, ER and DR values are significantly influenced only by the diameter of lung tumor, while localization or different histological types between the groups has no influence on this.
Introduction
Tumor imaging with various radiopharmaceuticals has been a focal point for nuclear medicine researchers. Currently used radiopharmaceuticals are nonspecific and most of them are also accumulated by benign tumors and infectious lesions, such as inflammatory lesions, abscess or granulomatous lesions. Some factors such as the choice of radiopharmaceutical applied, histopathologic type of tumor, its size, location or previous tumor treatment could influence sensitivity of tumor imaging.
Commonly used radiopharmaceuticals in lung cancer imaging are 201 Tl-chloride (talium-201 chloride) and 99m Tc-MIBI (technetium-99m labelled hexakis-2-methoxyisobutylisonitrile) [1] [2] [3] . New studies introduce simultaneous double-tracer single photon emission tomography (SPECT) with 99m-Tctechnetril and 67-Ga-citrate for follow-up of patients with nonsmall cell lung cancer 4 . Studies in vitro in cultured tumor cells found out that the uptake of 201 Tl is almost 3-fold greater than 99m Tc-MIBI, while the cellular release or the washout rate is almost identical for both radiopharmaceuticals 5 . Kinetics of some radiopharmaceuticals can be changed by adding certain drugs such as actinomycin D resulting in increased cellular release of 201 Tl while it has no change in washout rate of 99m Tc-MIBI 6 . Slower washout of 201 Tl in high growth cells enables this tracer to act as an indicator of tumor malignancy. Some papers have reported the benefit of 201 Tl-chloride in detecting tumor malignancies which is determined by the grade of washout rate to normal tissue especially in lung cancer lesions and mediastinal lymph node metastases 6 . Among these two radiopharmaceuticals, 99m Tc-MIBI has been emphasized because of its superior physical characteristics such as shorter half-life, better dosimetry, and optimal photon energy peak. Moreover, it is continuously available for use, permits freedom in scheduling patients and the injected concentration is higher. Tc-MIBI which is used in everyday practice for myocardial perfusion imaging, also gains its roll in evaluating various malignant tumors such as breast carcinoma, thyroid cancer, central nervous system malignancies and lung cancer [7] [8] [9] . Recently, many papers have reported accumulation of this radiopharmaceutical within tumor lesion considering its role in differentiating benign from malignant lesions [10] [11] [12] but only few have evaluated factors related to kinetics, uptake and washout of radiopharmaceuticals [13] [14] [15] . One of the earliest studies considering the uptake and kinetics of 99m Tc-MIBI in malignant lung lesions was reported by Hassan et al 13 . This study is designed to investigate kinetics of 99m Tc-MIBI by investigating its early and delayed uptake, release of 99m Tc-MIBI in benign and malignant lung lesions and evaluating possible factors which could be involved in the kinetics of this radiopharmaceutical.
Methods
A total of 60 patients with lung lesions (LLs) was evaluated from 2006 to 2009 (45 males and 15 females, age 37-76 years, mean age ± SD: 56.70 ± 9.527 years). All the patients were divided into 2 groups: the group 1 included 30 patients with benign LLs, and the group 2 included 30 patients with malignant solitary pulmonary nodule (SPN). This study included only the patients who had been evaluated by chest computed tomography (CT) ( Tc-MIBI with dual-headed gammacamera equipped with low-energy, high resolution collimator. Delayed imaging was done 60-120 minutes after the intravenous injection of the radiopharmaceutical. Tc-MIBI was prepared according to the instructions of the manufacturer. The images were acquired every 20 seconds, at the angle of 3º, in a circular orbit of 180º per detector array, and stored in 64 × 64 matrix. The equipment was calibrated for a photopeak of 140 keV with a symmetric 20% window. The images were reconstructed in the coronal, transversal and sagital sections and both early and delayed images were evaluated qualitatively considering positive findings if there was an increased accumulation of the radiopharmaceutical in the lung area corresponding to the location of the LLs. Quantification of the images included evaluation of the uptake ratio on early (ER = early ratio) and delayed images (DR = delayed ratio) calculated on transverse slices placing region of interest (ROI) around abnormal uptake of To test the differences between ER, DR and RI in benign (group 1) and malignant (group 2) LLs, Student's t-test was used. The results were considered significant when the p value was less than 0.05. Mutual and individual influence of diameter, localization, and histological type of LLs on uptake values (ER, DR, RI) and on 99m Tc-MIBI accumulation was analyzed with regression analysis.
Results

Visual evaluation of 99m
Tc-MIBI accumulation included positive and negative findings assessment on early and delayed images in both groups of patients. In the group 1, 23 (76.7 %) of the patients were negative on both early and delayed images: 8 inflammatory pseudonodules, 7 cases of tuberculosis, 6 hamarthoma, 1 primary neuroendocrine cyst and 1 fibrotic nodule. The majority of false positive results in the group 1 (7/30 or 23.3%) occurred in inflammatory pseudonodule and only one was the case of botryomycosis ( Figure 1 ).
Most of lung lesions from the group 2 were positive on both early and delayed images (27/30 or 90%): 9 adenocarcinoma, 13 squamous-cell carcinoma, 3 large-cell carcinoma and 2 small-cell carcinoma ( Figure 2 ). The difference in ER values between groups was statistically significant (t = 3.982, p < 0.05).
Also, the difference in DR values between groups was statistically significant (t = 3.448, p < 0.05). There was no significant difference between the RI values in benign and malignant SPN (-7.512 ± 10.44 and -11.394 ± 5.945, respectively) ( Figure 6 ). Among the false positive results in the group 1 (7 patients with a benign lung lesions), 5 cases of inflammatory pseudonodule showed washout of the tracer on delayed images. No washout of the tracer was noticed in 2 cases of benign lung lesions (1 botryomycosis and 1 inflammatory pseudonodule) with high values of RI (24.6 and 10.8, respectively).
All the true positive malignant lung lesions (27/30) showed washout of the tracer on delayed images. A highest difference between early and delayed ratio was noticed among adenocarcinomas and smallest difference among small-cell carcinomas. Two cases of adenocarcinoma had the highest values of ER in the group 2 (ER = 2.9 and ER = 3.0), but there was no significant difference in the ER values among the different histopathological types in the group (p < 0.05).
In the group 1, according to histopathological type, false positive findings were registered in 7 cases of benign LLs (6 pneumonia and 1 botryomycosis) with high values of ER = 2.2 ± 0.4 and DR = 2.0 ± 0.5. Among the two different histopathological types of benign lung lesions leading to false positive findings, there was no significant difference in ER, DR and RI values. In the group 2, the lowest ER and DR values were found in large-cell carcinoma (1.7 ± 0.2 and 1.5 ± 0.2, respectively) followed by small-cell and squamouscell carcinoma with almost identical results (Table 1) .
Adenocarcinoma had the highest ER and DR values of all histopathological types (2.2 ± 0.7 and 1.9 ± 0.7, respectively). Among the 4 different histopathological types of lung carcinoma, there was no significant difference in ER, DR and RI values.
Considering the size, malignant lung lesions were divided into 3 groups (small: 0-1.9 cm; medium: 2.0-3.9 cm and large lesions: over 4 cm). The results showed that the values of both early and delayed ratio increased with the larger size (ER: small 1.5; medium: 1.9; large: 2.1 and DR: small 1.3; medium 1.7, and large 1.8). There was a significant difference in ER and DR values between smallest and medium or large lung lesions (p < 0.05). There was no significant difference in retention index values compared to size of lung lesion ( Table 2) .
The values of ER, DR and RI were analyzed for lung lesions in both groups considering its localization in the right or the left lung and its lobes. In the group 1, 17 lesions were found in the left (10 were located in the lower lobe, 7 in the upper lobe) and 13 in the right lung (7 in the lower lobe, 5 in the upper lobe and 1 in the middle lobe). Among the lung lesions in the group 2, 16 were located in the right (6 in the upper, 5 in the middle and 5 in the lower lobe), and 14 in the left lung (8 in the upper and 6 in the lower lobe). No significant difference was found in ER, DR and RI values between the group 1 and the group 2 considering localization of lung lesions.
Regression analysis was used to evaluate how size, localization, histopathological report, ER and DR values influence (Figure 7 ). 
Discussion
The uptake mechanism of 99m Tc-MIBI by tumor cells is not yet known but there are some possible factors influencing the uptake such as the amount of mitochondria in the cell, cell membrane potential, increased tumor blood flow and capillary permeability. 16 It is known that accumulation of 99m Tc-MIBI in the tumor cell is reversely proportional to the level of P-glycoprotein (Pgp), the protein responsible for the transport of many chemotherapeutic drugs, thus increased Pgp level in the tumor is related to the resistance of malignant tumor to chemiotherapy 17 . Increased levels of Pgp were found in tumor biopsies from relapsing cancer patients. Accumulation of 99m Tc-MIBI in cells is inversely proportional to the level of Pgp. Tc-MIBI uptake is dependent on negative potential of the cytoplasmatic and mitochondrial membrane of neoplastic cells, showing increased accumulation in cells with higher number of mitochondria 19 . We found no significant difference in retention index values between the group 1 and the group 2. Therefore, the result suggests that the 99m Tc-MIBI uptake ratio is more useful as a parameter for either benign or malignant lung lesion than values of RI. Our results are confirmed with previously reported in vitro studies with Hela cells where washout rate of 99m Tc-MIBI from cultured cells was not related to their malignant potential 5 . Nishiyama et al. 20 agree with the conclusion that there is no significant tumor washout of 99m Tc-MIBI from the tumor mass according to RI values. Concurrently, some papers report no significant difference in ER and DR values or RI of 99m Tc-MIBI between benign and malignant lung lesions 21 . In our study, ER and DR values were greater in malignant than in benign lesions of the lung (1.4-fold greater and 1.36-fold greater, respectively) which is the case in numerous studies 13, 22, 23 . Hassan et al. 13 investigated accumulation of 99m Tc-MIBI in 19 patients on planar images, and reported even higher DR values: 1.58-fold greater in tumor tissue than in normal lung tissue at 30 minutes. Compared to these results, our lower DR values could be explained with the methodology of our study, calculating DR on images after 60 to 120 minutes.
Our study came up with the result that the size of lung lesion significantly affects ER and DR values tending to increase values of ER and DR in larger lesions which is in concordance with the results of other papers 20, 22 . Nishiyama et al. 20 investigated 45 patients with malignant lung lesions divided by size ( 3 cm, 6 and 6 cm) and reported higher ER and DR values of 99m Tc-MIBI (ranged from 2.1-3.3 and 1.9-3.0, respectively) than in our study but with the same growing tendency as the size of lung lesion increases. Minai et al. 11 reported a correlation of quantitative uptake of 99m Tc-MIBI with the diameter of the nodule with a correlation coefficient of 0.61 (p = 0.02). However, several studies reported no influence of sex, age, size of tumor and histological type on 99m Tc-MIBI accumulation results [22] [23] [24] . In benign group of patients (the group 1) false positive results occurred in 7 out of 30 benign lesions, 6 in inflammatory pseudonodule and 1 in botryomycosis. It is wellknown that chronic inflammation and active pulmonary tuberculosis could lead to high 99m Tc-MIBI uptake due to tissue factors such as high degree of tissue vascularization and capillary permeability. Alterations in cell metabolism that affect membrane potential, as might be the case in inflammatory lung lesions, could influence accumulation of 99m Tc-MIBI. Furthermore, a rich mitochondrial content of epitheloid cells in granulomas might be a key point for 99m Tc-MIBI uptake in tuberculosis 25 . Onsel et al. 26 investigated 99m Tc-MIBI accumulation in extensive pulmonary dis- 20 report that squamous-cell carcinoma has lower ER and DR values compared to adenocarcinoma (concordant to our results) and small-cell carcinoma (discrepant to our results). Hassan et al. 13 found that adenocarcinoma and small-cell carcinoma have higher T/N values than squamous-cell carcinoma, but the results of our study show equal accumulation of 99m Tc-MIBI in both squamous-cell and small-cell carcinoma. These authors also highlight that undifferentiated squamous-cell carcinoma can show no accumulation of 99m Tc-MIBI, a finding that was confirmed in our study by the one case of this pathohistological cancer type which was negative on 99m Tc-MIBI scan. In our study the finding that small-cell carcinoma has similar ER values as squamous-cell is in discrepancy with the Sahin et al. 28 results showing lower uptake of 99m Tc-MIBI in squamous-cell than small-cell carcinoma (1.22 ± 0.14 and 1.39 ± 0.1, respectively) with a significant difference in ER and DR values between these two histopathological types of lung cancer.
There are certain limitations of our patients population preventing us to give final conclusion about the correlation between histological type and 99m Tc-MIBI scan results. Firstly, in our study on 30 patients with malignant lung lesions, there were only 2 cases of small-cell carcinoma with respect to 27.2% of cases reported by Hassan et al. 13 . Secondly, the majority of malignant lung lesions in our patients were squamous-cell carcinoma, with a low prevalence of large-cell carcinoma.
Conclusion
This study suggests that the uptake ratio of 99m Tc-MIBI (early and delayed ratio) could be a useful index in evaluating benign and malignant lung lesions, while retention index has no influence on this. Considering the factors related to uptake and release of the radiopharmaceutical, there was a significant difference in ER and DR values between smallest and medium or large lung lesions, while there was no significant difference in retention index values. Other investigated factors, such as localization of the lesion or different pathohistological types among benign or malignant lesions, showed no influence on the values of ER, DR or RI.
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